Johnson & Johnson

Johnson & Johnson is a U.S.-based healthcare company founded in 1887 that develops, manufactures, and sells products for human health and well-being. It operates through two segments, Innovative Medicine and MedTech, with businesses spanning prescription medicines, surgical and interventional technologies, and other healthcare products sold in virtually all countries.

67,9 %

28,5 %

+6,0 %

1.03

0.77

— Johnson & Johnson
%
Innovative Medicine64% Prescription pharmaceuticals and biologics for major therapeutic areas including immunology, oncology, neuroscience, and cardiovascular disease.
MedTech36% Medical devices and technology used in surgery, orthopaedics, interventional procedures, and vision care.

Johnson & Johnson sells primarily to healthcare providers, hospitals, clinics, distributors, and other institutional...

  • Healthcare providers and hospitalsprimary

    Buy surgical, interventional, and orthopaedic devices for procedures and patient care.

  • Physicians and specialty prescribersprimary

    Prescribe Innovative Medicine products in immunology, oncology, neuroscience, and cardiovascular care.

  • Wholesalers and distributorsprimary

    Purchase and redistribute products across the U.S. and international healthcare channels.

  • Payers and government health systemssecondary

    Influence access, reimbursement, and pricing for both medicines and devices.

  • Patientssecondary

    End users of therapies and devices, especially in chronic and specialty care settings.

Johnson & Johnson operates in virtually all countries, with the U.S. as its largest market and a broad international...

  • •U.S. is the largest market and key source of segment sales
  • •Europe is a major international market with positive currency impact
  • •Western Hemisphere excluding the U.S. contributes diversified international demand
  • •Asia-Pacific and Africa add growth exposure and regulatory complexity
  • •Operations span virtually all countries through local subsidiaries

Johnson & Johnson is focused on innovation-led growth across its two healthcare segments, supported by heavy R&D...

01
Sustain innovation through R&D and new product launchesmedium-term

The company competes on clinical differentiation, intellectual property, and product performance.

02
Manage portfolio mix and simplify the businessmedium-term

Portfolio focus can improve capital allocation and reduce complexity across segments.

03
Expand globally while adapting to local market conditionslong-term

International growth depends on reimbursement, regulation, and distribution by country.

Johnson & Johnson faces intense competition in both pharmaceuticals and devices, where product performance, pricing,...

high

Competitive pressure across both segments

The company competes on innovation, pricing, reimbursement, and intellectual property in all markets.

Scope
Innovative Medicine and MedTech
Materiality
high
high

Patent loss and biosimilar competition

Loss of exclusivity can sharply reduce sales of branded medicines.

Scope
Innovative Medicine, including STELARA-related pressure
Materiality
high
high

Cybersecurity and information security incidents

The company relies on internal and third-party systems for sensitive data, supply chain, and product delivery.

Scope
Enterprise-wide IT and connected products
Materiality
high
high

Healthcare reform and pricing pressure

Government and payer actions can compress pricing and limit access to products.

Scope
U.S. and international markets
Materiality
high
medium

Counterfeit and diverted products

Illegal distribution channels can harm patients, reduce sales, and trigger recalls or litigation.

Scope
Global markets and internet channels
Materiality
medium
Revenue recognition and variable consideration
Can materially affect reported sales and margins when estimates change
Rebate and return accruals
Affects revenue, receivables, and operating profit
Goodwill and intangible asset impairment
Potential non-cash charges if product performance weakens
Legal and product liability contingencies
Can create material provisions and cash outflows
Pension and employee benefit assumptions
Can move operating expense and other comprehensive income

Merck & Co., Inc.

MRK · Pharmaceutical Preparations

PFIZER INC

PFE · Pharmaceutical Preparations

HCA Healthcare, Inc.

HCA · Services-General Medical & Surgical Hospitals, NEC

Johnson Controls International plc

JCI · Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip

BOSTON SCIENTIFIC CORP

BSX · Surgical & Medical Instruments & Apparatus

Medtronic plc

MDT · Electromedical & Electrotherapeutic Apparatus

: 11/08/2026